FIGS, Inc.: insider trades · United States · SEC (Form 4)

About FIGS, Inc.

FIGS, Inc. is a United States-based company listed on the NYSE under the ticker FIGS, with headquarters in Santa Monica, California. Founded in 2013, the company has built a direct-to-consumer healthcare apparel brand focused on medical uniforms and related products for healthcare professionals. From an equity research perspective, FIGS stands out as a premium brand in a historically fragmented and underbranded category, where it has attempted to elevate scrubs from a commodity product into a design-led, technically differentiated offering. The company’s business is organized around two primary product lines. The core category is scrubwear: medical workwear designed to meet the functional needs of clinicians while emphasizing comfort, durability, and style. The second category is non-scrubwear, which includes outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. FIGS positions these offerings as an integrated system that serves healthcare professionals both on and off shift. FIGS primarily sells through its digital direct-to-consumer platform, including its website and mobile app, which gives the company direct access to consumer demand, brand engagement data, and merchandising insights. It also operates physical “Community Hubs,” which function as brand experiences rather than a traditional wholesale retail footprint. In addition, the company has built TEAMS, a B2B channel aimed at hospitals, clinics, and other healthcare organizations. Competitively, FIGS has carved out a strong position in premium healthcare apparel, supported by a well-known brand, a loyal customer base, and a product strategy that blends performance features with lifestyle positioning. The market remains competitive, however, with pressure from specialist apparel players and broader uniform brands. FIGS’ differentiators are its brand equity, direct customer relationship, in-house product development, and data-driven inventory and replenishment model. The company’s filings indicate a customer base of several million active customers and a business that remains heavily concentrated in the United States, although it also operates through FIGS Canada, Inc. Recent highlights are important for investors. In early 2026, FIGS reported full-year 2025 results and said fourth-quarter net revenue rose sharply year over year, alongside better profitability metrics. Management also pointed to low double-digit revenue growth and margin expansion as objectives for fiscal 2026. For French-speaking investors, FIGS is best viewed as a specialty consumer-healthcare brand with exposure to healthcare employment trends, brand loyalty, and execution on growth, profitability, and merchandising discipline.